Advanced Tissue Sciences' skin replacement approved
This article was originally published in Clinica
Advanced Tissue Sciences has received approval from the FDA to market its Dermagraft-TC temporary skin replacement in the US. The substitute skin is intended for people who are severely burned and in need of wound covering until their own skin can be grafted. Advanced Tissue Sciences, based in La Jolla, California, estimates that nearly 5,500 people die and at least 51,000 are hospitalised for burn treatment in the US each year.
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.